Adıyaman Üniversitesi Kurumsal Arşivi

Sulphonamides incorporating 1,3,5-triazine structural motifs show antioxidant, acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibitory profile

Basit öğe kaydını göster

dc.contributor.author Lolak, Nabih
dc.contributor.author Boğa, Mehmet
dc.contributor.author Tuneg, Muhammed
dc.contributor.author Karakoç, Gülçin
dc.contributor.author Akocak, Süleyman
dc.contributor.author Supuran, Claudiu
dc.date.accessioned 2025-08-26T05:30:01Z
dc.date.available 2025-08-26T05:30:01Z
dc.date.issued 2020
dc.identifier.issn 1475-6366
dc.identifier.uri http://dspace.adiyaman.edu.tr:8080/xmlui/handle/20.500.12414/6648
dc.description.abstract A series of 16 novel benzenesulfonamides incorporating 1,3,5-triazine moieties substituted with aromatic amines, dimethylamine, morpholine and piperidine were investigated. These compounds were assayed for antioxidant properties by using 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging assay, 2,2`-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) radical decolarisation assay and metal chelating methods. They were also investigated as inhibitors of acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and tyrosinase, which are associated with several diseases such as Alzheimer, Parkinson and pigmentation disorders. These benzenesulfonamides showed moderate DPPH radical scavenging and metal chelating activity, and low ABTS cation radical scavenging activity. Compounds 2 b, 3d and 3 h showed inhibitory potency against AChE with % inhibition values of >90. BChE was also effectively inhibited by most of the synthesised compounds with >90% inhibition potency. Tyrosinase was less inhibited by these compounds. tr
dc.language.iso en tr
dc.publisher TAYLOR & FRANCIS LTD tr
dc.subject Benzenesulfonamides tr
dc.subject 1 tr
dc.subject 3 tr
dc.subject 5-triazine tr
dc.subject enzyme inhibition tr
dc.subject Alzheimer's disease tr
dc.subject tyrosinase tr
dc.title Sulphonamides incorporating 1,3,5-triazine structural motifs show antioxidant, acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibitory profile tr
dc.type Article tr
dc.contributor.authorID 0000-0003-4163-9962 tr
dc.contributor.authorID 0000-0002-8747-4633 tr
dc.contributor.authorID 0000-0003-4506-5265 tr
dc.contributor.authorID 0000-0003-4262-0323 tr
dc.contributor.department Adiyaman Univ, Dept Pharmaceut Chem, Fac Pharm tr
dc.contributor.department Dicle Univ, Dept Analyt Chem, Fac Pharm tr
dc.contributor.department Univ Firenze, NEUROFARBA Dept, Sez Sci Farmaceut tr
dc.identifier.endpage 431 tr
dc.identifier.issue 1 tr
dc.identifier.startpage 424 tr
dc.identifier.volume 35 tr
dc.source.title JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY tr


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster